The Koryo Medicine General Hospital has achieved good results in putting Koryo therapies on a scientific base.
It made a breakthrough in the efforts to guarantee scientific classifica-tion of physical constitutions by using the indexes newly discovered through the study of the theoretical foundation and clinical features of constitutional medicine peculiar to the Korean nation.
The hospital also conducts research to shorten the period of treating incurable diseases and increase the efficiency of treatment.
In the course of this it has established Koryo therapies for over 10 in-curable diseases including ectopic disc pain and lumbar slipped disc.
It has also been successful in developing anti-cancer medicines based on Koryo medicinal materials.
It tested a mixture made from more than 30 medicinal herbs on cancer for years and conducted histopathological and immunological research into Ehrlich’s sarcoma-180 cancer carrier animal.
It obtained a tumour suppression rate of 65 percent through experi-ments and also tested on dendritic cells the world’s cancer researchers are trying to find out.
After conducting tens of rounds of experiments with sophisticated apparatuses, its researchers succeeded in making an insam-barrenwort anti-cancer tablet whose tumour suppression rate is higher than synthet-ic anti-cancer drugs.
The tablet received a national standard in October last year and its manufacturing technique obtained a patent of the DPRK in February this year.
The hospital presses ahead with the application of traditional Korean therapies to above-county-level hospitals in order to introduce them into clinical practice all across the country.
Eight European countries issue joint statement against tariff pressure by US
On January 18, Denmark, Finland, France, Germany, the Netherlands, Norway, Sweden and the UK issued a joint statement against the
January 26, 2026
On January 18, Denmark, Finland, France, Germany, the Netherlands, Norway, Sweden and the UK issued a joint statement against the
